panhpvax
Vaccineexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 23, 2022 (NCT05208710)
Timeline
2020s
- Jan 1, 2022
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Human papillomavirusImmunity, active
Human papillomavirus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05208710 | Early Phase 1 (Phase 1) | Nov 23, 2022 | German Cancer Research Center, Heidelberg University, University of Heidelberg |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| German Cancer Research Center | Academic/Hospital | 1 | 1 | 1 | 2022 |
| Heidelberg University | Academic/Hospital | 1 | 0 | 1 | 2022 |
| University of Heidelberg | Academic/Hospital | 1 | 0 | 1 | 2022 |
3 organizations
Page 1 / 1